Diversified Healthcare Trust Earnings Call Signals Momentum

Diversified Healthcare Trust ((DHC)) has held its Q1 earnings call. Read on for the main highlights of the call.

Diversified Healthcare Trust’s latest earnings call struck an optimistic tone, underscoring accelerating operational momentum and a steadily improving balance sheet. Management highlighted strong growth in its senior housing operating portfolio, better margins, and a recent credit upgrade, while acknowledging that leverage, interest coverage, and ongoing capital needs remain key watch points for investors.

FFO Beat and Robust EBITDAre Underscore Earnings Strength

Diversified Healthcare Trust reported normalized funds from operations of $33.1 million, or $0.14 per share, alongside adjusted EBITDAre of $74 million. Both metrics were described as comfortably ahead of analyst expectations, reinforcing the view that the operational recovery is now translating into tangible earnings outperformance.

NOI Growth Accelerates on Both Consolidated and Same‑Property Basis

Consolidated net operating income reached $75.9 million, representing a 4.7% increase from a year earlier. On a same‑property cash basis, NOI climbed 8.6% year over year and 7.8% sequentially, signaling broad‑based improvement across the portfolio rather than isolated strength in a handful of assets.

SHOP Portfolio Emerges as Engine of Growth

The senior housing operating portfolio delivered standout performance, with same‑property NOI up 13.5% year over year to $44.3 million. Occupancy improved by 110 basis points to 82.4%, average monthly rates grew about 5.9%, and margins expanded by 160 basis points to 14.9%, underscoring both demand recovery and improved pricing power.

Cost Controls Drive Margin Expansion Across Operations

Management detailed significant expense progress, including nearly a 35% year‑over‑year drop in contract labor and a 370 basis point sequential decline in dietary costs. Labor costs (on an adjusted basis) fell 70 basis points sequentially, and same‑property expense growth moderated by 350 basis points year over year, contributing to notable margin expansion.

High‑Return Capital Projects Target Accretive Growth

The company is pursuing a disciplined pipeline of investments across 16 communities, with an initial wave of six projects costing about $20 million. These projects will add roughly 150 units and are expected to be immediately accretive, with projected returns starting in the mid‑teens and a cost per unit well below estimated replacement cost.

Medical Office & Life Science Segment Delivers Steady Gains

In the medical office and life science portfolio, same‑property occupancy rose 60 basis points to 95.3%, driving NOI of $25.4 million, up 3.7% year over year and 4.8% sequentially. The trust executed 169,000 square feet of new and renewal leases at rents roughly 12% above prior levels, with a weighted average lease term of 9.5 years and additional leasing momentum in the following quarter.

Liquidity Position and Balance Sheet Flexibility Improve

The REIT ended the quarter with $272 million of total liquidity, including $122 million of cash and a fully available $150 million credit facility. With about 197 unencumbered properties representing roughly 64% of gross book value and no debt maturities until 2028 after recent refinancings, management emphasized greater financial flexibility.

Leverage and Interest Coverage Trending Better but Still Elevated

Net debt to annualized adjusted EBITDAre improved to 7.8 times from 8.8 times a year ago, moving closer to the firm’s 6.5 to 7.5 times near‑term target range. Adjusted EBITDAre to interest expense rose to 2.0 times from 1.3 times, a meaningful improvement that still leaves interest coverage at only moderate levels versus more conservative REIT peers.

Capital Recycling and Strategic Dispositions Sharpen Portfolio

The company continued recycling capital by selling 13 unencumbered non‑core senior housing communities for $23 million. It also exercised land lease purchase options on two properties for $14.5 million to eliminate ground rent and capture full economics, with management expecting low‑ to mid‑teen returns on these land acquisitions.

Credit Upgrade and Outsized Stock Performance Highlight Turnaround

Moody’s upgraded Diversified Healthcare Trust’s corporate family rating to B3 from Caa1 and assigned a positive outlook, citing improving fundamentals. The market has taken notice, with the stock up roughly 60% year to date, far outpacing the S&P 500 and major REIT benchmarks, reflecting growing investor confidence in the turnaround.

Occupancy Seasonality and Rollover Risk Temper the Outlook

Senior housing occupancy was flat sequentially at 82.4%, with management pointing to seasonal patterns and operator transitions as temporary headwinds, though it still expects gains later in the year. In the medical office and life science segment, around 9% of annualized rental income is set to expire by 2026, with roughly 304,000 square feet expected to vacate, creating near‑term leasing and vacancy risk.

Ongoing CapEx Needs and G&A Variability Remain Key Considerations

Recurring capital expenditures remain sizable, guided at $100 million to $115 million in 2026, including $80 million to $90 million for SHOP and a maintenance run‑rate of about $3,500 per unit, though this is expected to decline over time. General and administrative expenses were elevated by $6.6 million of incentive fees tied to stock performance, and management cautioned that these business management fees can remain volatile.

One‑Time Transition Costs and Insurance Proceeds Affect Comparability

Portfolio transitions, including the integration of AlerisLife operations, generated transaction‑related costs below NOI and some short‑term disruption, though management said the transitions are progressing well. Prior‑year results also included $2.7 million of business interruption insurance proceeds, and adjusting for that item would have lifted reported SHOP same‑property NOI growth to about 22% year over year.

Guidance and Outlook Signal Continued Momentum Through 2026

Management reaffirmed full‑year 2026 guidance, projecting SHOP NOI of $175 million to $185 million, medical office and life science NOI of $94 million to $98 million, and triple‑net senior living and wellness NOI of $28 million to $30 million. The company expects adjusted EBITDAre of $290 million to $305 million, normalized FFO of $0.52 to $0.58 per share, recurring CapEx of $100 million to $115 million, and is targeting about a 300 basis point tenancy increase in SHOP occupancy with at least 5% rate growth, while working leverage down into a 6.5 to 7.5 times band.

Diversified Healthcare Trust’s earnings call painted a picture of a REIT firmly in recovery mode, with operational momentum now clearly reflected in earnings and credit metrics. While leverage, seasonal occupancy, and recurring capital needs remain areas to monitor, investors are being rewarded for the risk, as improved fundamentals, disciplined capital allocation, and a stronger balance sheet underpin a more durable growth trajectory.